Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Christopher Thomas Ford"'
Autor:
Toni Thenhausen, Nuray Akyüz, Thorben Mährle, Sonja Loges, Eray Goekkurt, Julia Quidde, Alexander Stein, Carsten Bokemeyer, Benjamin Thiele, Anna Brandt, Simon Schliffke, Janina Radloff, Thomas Haalck, Mascha Binder, Anne Marie Asemissen, Christopher Thomas Ford, Artus Krohn-Grimberghe
Publikováno v:
International Journal of Cancer. 140:2535-2544
Cancer immunotherapy with antibodies targeting immune checkpoints, such as programmed cell death protein 1 (PD-1), shows encouraging results, but reliable biomarkers predicting response to this costly and potentially toxic treatment approach are stil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2e5c9b06dcbec51c32fea54d0d0addc
https://doi.org/10.1002/ijc.30549
https://doi.org/10.1002/ijc.30549
Autor:
Mascha Binder, Janina Radloff, Benjamin Thiele, Christopher Thomas Ford, Artus Krohn-Grimberghe, Manuela März, Minna Voigtlaender, Anita Schulenkorf, Nuray Akyüz, Anna Oberle, Malik Alawi, Anna Brandt
Publikováno v:
Haematologica
Recent studies suggest that circulating tumor cells and cell-free DNA may represent powerful non-invasive tools for monitoring disease in patients with solid and hematologic malignancies. Here, we conducted a pilot study in 27 myeloma patients to exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8451efb11b1bf2e2e497d6cd61913527
http://europepmc.org/articles/PMC5451343
http://europepmc.org/articles/PMC5451343
Autor:
Simon Schliffke, Nuray Akyüz, S Knop, Christopher Thomas Ford, Manfred Binder, Artus Krohn-Grimberghe, Toni Thenhausen, Carsten Bokemeyer, Thorben Mährle
Publikováno v:
Leukemia. 30:2232-2234
Clinical response to ibrutinib is accompanied by normalization of the T-cell environment in CLL-related autoimmune cytopenia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20079857300d12e2ff834f0f2efb11a4
https://doi.org/10.1038/leu.2016.157
https://doi.org/10.1038/leu.2016.157
Autor:
Nuray, Akyüz, Anna, Brandt, Alexander, Stein, Simon, Schliffke, Thorben, Mährle, Julia, Quidde, Eray, Goekkurt, Sonja, Loges, Thomas, Haalck, Christopher Thomas, Ford, Anne Marie, Asemissen, Benjamin, Thiele, Janina, Radloff, Toni, Thenhausen, Artus, Krohn-Grimberghe, Carsten, Bokemeyer, Mascha, Binder
Publikováno v:
International journal of cancer. 140(11)
Cancer immunotherapy with antibodies targeting immune checkpoints, such as programmed cell death protein 1 (PD-1), shows encouraging results, but reliable biomarkers predicting response to this costly and potentially toxic treatment approach are stil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::903b9b32d3ac99e9e153d3ee870a2954
https://pubmed.ncbi.nlm.nih.gov/27925177
https://pubmed.ncbi.nlm.nih.gov/27925177